Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesamorelin in Abdominal Obesity
NCT00675506Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2008
- Primary completion
- Jan 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of tesamorelin in abdominal obesity, growth hormone deficiency (GHD), sponsored by Massachusetts General Hospital. Started Jul 2008; status: completed.
02
Drugs
tesamorelin
03
Conditions
abdominal obesitygrowth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00675506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00675506.